JNBA Financial Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

JNBA Financial Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-400	Closed	-$46.3K	–	761
2023 Q3	$46.3K	Hold	400	–	–	0.01%	284
2023 Q2	$41.1K	Hold	400	–	–	﹤0.01%	307
2023 Q1	$43.7K	Hold	400	–	–	0.01%	298
2022 Q4	$45.5K	Hold	400	–	–	0.01%	287
2022 Q3	$25K	Hold	400	–	–	﹤0.01%	351
2022 Q2	$32K	Hold	400	–	–	﹤0.01%	333
2022 Q1	$42K	Hold	400	–	–	0.01%	312
2021 Q4	$43K	Hold	400	–	–	0.01%	326
2021 Q3	$44K	Hold	400	–	–	0.01%	309
2021 Q2	$37K	Hold	400	–	–	0.01%	326
2021 Q1	$37K	Hold	400	–	–	0.01%	319
2020 Q4	$29K	Hold	400	–	–	﹤0.01%	322
2020 Q3	$31K	Hold	400	–	–	0.01%	292
2020 Q2	$22K	Hold	400	–	–	﹤0.01%	325
2020 Q1	$12K	Hold	400	–	–	﹤0.01%	367
2019 Q4	$14K	Hold	400	–	–	﹤0.01%	397
2019 Q3	$11K	Hold	400	–	–	﹤0.01%	402
2019 Q2	$10K	Buy	+400	New	+$10.1K	﹤0.01%	440

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.51B AUM 13.02% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

JNBA Financial Advisors's HZNP Position: Q4 2023 in Review

JNBA Financial Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 400 shares — an estimated $46.3K sold.

JNBA Financial Advisors first reported a position in HZNP in Q2 2019 and held it in 18 quarters. The position peaked at $46.3K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

JNBA Financial Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
JNBA Financial Advisors sold 400 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $46.3K.
JNBA Financial Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 18 quarters.
JNBA Financial Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $46.3K in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on JNBA Financial Advisors's 13F filing for Q4 2023, filed 8 Feb 2024.